Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2026-07-02 @ 7:09 PM
Study NCT ID:
NCT05346666
Status:
UNKNOWN
Last Update Posted:
2022-11-15
First Post:
2022-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Possible Immuno-Modulatory Effect of Tocilizumab in Patients With Refractory Status Epilepticus.
Sponsor:
Damanhour University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Epilepsy | View |
Keywords: